Category Archives: "INforMS"

Gray matter atrophy tied to specific disabilities in multiple sclerosis
Specific disabilities in multiple sclerosis (MS) were associated with voxelwise gray matter loss in distinct locations, a cross-sectional [...]
Processed foods and additives may lead to multiple sclerosis, autoimmune diseases
Processed foods have been added to the list of “no-no” items that we are not supposed to eat if you, like me, are unfortunate enough to [...]
Multiple sclerosis therapy can ‘reverse disease’
A radical treatment can halt the progression of multiple sclerosis and even reverse symptoms of the autoimmune disease, research [...]
Immune ablation before stem cell transplant works in multiple sclerosis
A myeloablative protocol similar to those used in hematologic malignancies is feasible as a prelude to autologous hemapoietic stem cell [...]
‘Multiple sclerosis does not remit’ – call to change RRMS name to relapsing multiple sclerosis
MS does not remit and the out dated term causes many people to delay taking medication, says Dr Patricia Coyle, Founder and Director of [...]
Sluggish bowels may increase fatigue in multiple sclerosis
NATIONAL HARBOR, Md. -- Sluggish bowels may be contributing to fatigue among multiple sclerosis (MS) patients, according to a small study [...]
Immunotherapy-transplant combo works in multiple sclerosis
NATIONAL HARBOR, Md. -- A combination of high-dose immunosuppressive therapy and autologous hematopoietic cell transplantation resulted in [...]
Genetic link to multiple sclerosis found
For the first time, scientists say they’ve discovered a genetic mutation linked to a rare type of multiple sclerosis, and they are hoping [...]
Mitoxantrone may boost colon cancer risk in multiple sclerosis
Multiple sclerosis patients taking the drug mitoxantrone had a higher incidence of colorectal cancer and acute myeloid leukemia (AML) than [...]
Ankrd55: a new gene involved in multiple sclerosis is discovered
Multiple Sclerosis (MS) is a neurological disease, characterised by demyelination and the onset of chronic, neurodegenerative damage of the [...]
  • (201) 487-1050
  • 3 University Plz Dr Ste 116, Hackensack, NJ 07601
  • info@mscare.org

Upcoming Testing Periods

WINTER 2024 TESTING PERIOD

Application Deadline: December 6th, 2023

First Day of Testing: Saturday, January 6th, 2024

Last Day of Testing: Saturday, January 20th, 2024

SUMMER 2024 TESTING PERIOD

Application Deadline: May 1st, 2024

First Day of Testing: Saturday, June 1st, 2024

Last Day of Testing: Saturday, June 15th, 2024

Resources

Visit PTC to download a PDF version of the Handbook. Candidates can also apply online.

For more information:

Professional Testing Corporation http://www.ptcny.com/

  • 212-356-0660
  • 1350 Broadway, 17th Floor, New York, NY 10018

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM